Cited by 196Cerebrovascular and genetic disordersNeurological Disease Mechanisms and TreatmentsGenetic Neurodegenerative Diseases

The DOI matches its Crossref record, with a small difference in title or year; 136 of the 138 references it cites were found in a registry or an index.

CADASIL and CARASIL

Open access

Abstract

CADASIL and CARASIL are hereditary small vessel diseases leading to vascular dementia. CADASIL commonly begins with migraine followed by minor strokes in mid‐adulthood. Dominantly inherited CADASIL is caused by mutations (n > 230) in NOTCH 3 gene, which encodes Notch3 receptor expressed in vascular smooth muscle cells ( VSMC ). Notch3 extracellular domain ( N 3 ECD ) accumulates in arterial walls followed by VSMC degeneration and subsequent fibrosis and stenosis of arterioles, predominantly in cerebral white matter, where characteristic ischemic MRI changes and lacunar infarcts emerge. The likely pathogenesis of CADASIL is toxic gain of function related to mutation‐induced unpaired cysteine in N 3 ECD . Definite diagnosis is made by molecular genetics but is also possible by electron microscopic demonstration of pathognomonic granular osmiophilic material at VSMC s or by positive immunohistochemistry for N 3 ECD in dermal arteries. In rare, recessively inherited CARASIL the clinical picture and white matter changes are similar as in CADASIL , but cognitive decline begins earlier. In addition, gait disturbance, low back pain and alopecia are characteristic features. CARASIL is caused by mutations (presently n = 10) in high‐temperature requirement. A serine peptidase 1 ( HTRA 1 ) gene, which result in reduced function of HTRA 1 as repressor of transforming growth factor‐β ( TGF β) ‐signaling. Cerebral arteries show loss of VSMC s and marked hyalinosis, but not stenosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bpa.12181

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 138 references

2 of the 138 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Bogaert L, 1955, Encephalopathie sous‐corticale progressive (Binswanger) a evolution rapide sous deuz soeurs, Med Hellen, 24, 961

Cited by

Sorted by citations

Items 101–196 of 196

Metadata

Authors
Tikka, S., Baumann, M., Siitonen, M., Pasanen, P., Pöyhönen, M., Myllykangas, L., Viitanen, M., Fukutake, T., Cognat, E., Joutel, A., & Kalimo, H.
Affiliations
  • University of Helsinki (FI)
  • University of Turku (FI)
  • Helsinki University Hospital (FI)
  • Karolinska Institutet (SE)
  • Kameda Medical Center (JP)
  • Inserm (FR)
Corresponding author
Kalimo, Hannu
Venue
Brain Pathology
Publisher
Wiley
Published
2014-09
Volume
24
Issue
5
Pages
525-544
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W1604840218
Cited by
189
References
138
Citations by year
2026: 6 · 2025: 20 · 2024: 14 · 2023: 19 · 2022: 19 · 2021: 15 · 2020: 17 · 2019: 20 · 2018: 24 · 2017: 10 · 2016: 13 · 2015: 10 · 2014: 1
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • Brain Pathology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Fondation Leducq
  • Finnish Cultural Foundation
  • Sigrid Juselius Foundation
  • Swedish Research Council
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
CADASIL, CARASIL, vascular dementia, NOTCH3 mutations, vascular smooth muscle cells, osmiophilic granules, lacunar infarction, TGF-beta signaling, gain-of-function, hyalinosis
MeSH terms
Alopecia, Brain, Cerebral Infarction, Humans, Spinal Diseases, CADASIL, Leukoencephalopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review